Clinical Trial Update: Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient [Phase 4]

View source ↗

Summary

Update on a Phase 4 clinical trial evaluating the effects of Vitamin A on gene expression in patients with relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Vitamin A (retinol)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: UNKNOWN